A pharmaceutical composition for inhalation comprising aclidinium in the formof a dry powder of a pharmaceuticallyacceptable salt in admixture with a pharmaceutically acceptable dry powdercarrier, providing a metered nominal dose ofaclidinium equivalent to about 400 µg aclidinium bromide.